Schizophrenia is a neuro-psychiatric disorder that affects about one percent of the global population. To date, the diagnosis of mental illnesses is highly subjective and mostly based on clinical interviews. This could now be backed by a new, low-cost blood test developed as part of a European research project. Researchers at the Department of Chemical Engineering and Biotechnology at the…
Read more: http://ift.tt/1Ak7Dkz
No comments:
Post a Comment